ROIV
Roivant Sciences Ltd. · Healthcare
Pres, Immunovant CEO Eric Venker sold $4.4M of Roivant Sciences Ltd.
Sold$4,384,000
$21.92Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Thu, Jan 15 open, $23.76
- +18.3%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Mar 2 close.
Traded Mon, Jan 12. Filed Wed, Jan 14, 9:00 PM ET, after the close. Returns use the Jan 15 open and the Mar 2 close. Not investment advice.